Horan Christopher sold $80K of ARTV
Horan Christopher (Chief Tech Operations Officer) sold 20,546 shares of Artiva Biotherapeutics, Inc. (ARTV) at $3.91 on 2026-11-17.
How this was made
The 30-second read
Why it matters
Insider selling can influence sentiment, but this disclosure alone does not provide new operational or financial information about Artiva.
Market read
Traders may note the modest insider sale as a sentiment datapoint, but it is unlikely to drive a material repricing without accompanying company news.
What to watch
No 10b5-1 plan is cited, but the article does not provide context on prior grants, tax events, or whether sales were part of a broader planned schedule.
Background
The article is an SEC Form 4 insider transaction for Artiva Biotherapeutics, Inc. (ARTV).
Ticker impact
Artiva Biotherapeutics insider Horan Christopher sold 20,546 shares at $3.9119 on 2026-11-17, totaling about $80.4K, per Form 4.
Likely limited downside pressure or neutral reaction as the market treats it as non-fundamental insider selling.
The filing is an insider transaction disclosure, not an earnings, guidance, deal, or regulatory event; the dollar value is modest and there is no stated company-specific catalyst.
Market effects
Minimal, as this is a single-company insider sale without sector-wide signal.
None indicated.
None indicated.
Counterpoint
The sale may be for diversification or personal liquidity needs and does not necessarily reflect negative views on Artiva’s prospects.
Key entities
- issuerArtiva Biotherapeutics, Inc.
US-listed biotech subject of the Form 4 insider sale by its Chief Tech Operations Officer.
- insiderHoran Christopher
Chief Tech Operations Officer who sold 20,546 shares on 2026-11-17.



